Company / Current Liabilities
Vera Therapeutics, Inc. Current Liabilities History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$53.5M
FY2025
5-year range
$7.7M / $53.5M
FY2021-FY2025
Trend
+110.7%
vs FY2024
Sector context
#138 of 213
Health Care
What the data says
At $53M, Vera Therapeutics, Inc.'s current liabilities ranks #76 of 213 in the Health Care sector. Increased from $22M to $53M over the past 2 years.
Based on SEC 10-K filings.
$53M in FY2025 with a 5-year CAGR of +85.9%.
Increased from $22M to $53M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +27.8%
- 5-Year CAGR
- +85.9%
- 10-Year CAGR
- -
Sector benchmark
#76 of 213 in Health CareTop 35% of 213This company $53.5M Sector average $1.6B
▼
-96.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +85.9%, indicating consistent growth.
- In FY2025, current liabilities increased 110.7% year-over-year.
- Ranks #138 out of 213 companies in the Health Care sector.
- Lowest current liabilities in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $53.5M | +110.7% |
| FY2024 | $25.4M | +13.8% |
| FY2023 | $22.3M | -12.9% |
| FY2022 | $25.6M | +232.9% |
| FY2021 | $7.7M | +219.6% |
| FY2020 | $2.4M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026